Literature DB >> 27407671

von Willebrand Disease : A Clinico-haematological Spectrum.

D K Mishra1, A Chaturvedi2, A Sharma3, H Subramanya4, Harsh Kumar5, R Varadarajulu6, K P Anand7.   

Abstract

BACKGROUND: Bleeding disorders are commonly seen in clinical practice. von Willebrand Disease (vWD), is the commonest and yet a profoundly under diagnosed cause, having a wide spectrum of clinical presentation. Of its three types, type 1 vWD (70% of the total vWD cases) has the mildest and a highly variable clinical and laboratory presentation.
METHODS: A series of ten cases of vWD were comprehensively evaluated using recommended diagnostic parameters and therapeutic interventions.
RESULTS: All major types of vWD were represented. A female preponderance, with primary presentation in the form of muco-cutaneous bleeds was observed. A positive history of consanguineous parental marriage and family history of bleeding disorder was elicited in two and three patients respectively. Nine patients were found to be anemic and thrombocytopenia was present in only one. Bleeding time by modified template (SIMPLATE) method, along with activated partial thromboplastin time (APTT) was increased in all ten cases and of these, nine had low factor VIII: C levels. Ristocetin induced platelet aggregation studies were abnormal in all the five cases it was performed. vWF:RCo activity determined in one individual was shown to be low. vWF:Ag assay was done in four cases revealing a near complete absence of von Willebrand factor antigen in one and mildly decreased levels in the other three. vWF multimer assay was advised in three cases. DDAVP, plasma derived vWF, blood products and local antifibrinolytics were used as primary modalities of treatment.
CONCLUSION: Thus, strong clinical suspicion, thorough clinical evaluation and judicious use of investigations including repeated investigations at different times are needed for making a diagnosis of vWD.

Entities:  

Keywords:  Bleeding disorders; von Willebrand Disease

Year:  2011        PMID: 27407671      PMCID: PMC4923447          DOI: 10.1016/S0377-1237(04)80006-6

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  12 in total

Review 1.  A critical reappraisal of the bleeding time.

Authors:  R P Rodgers; J Levin
Journal:  Semin Thromb Hemost       Date:  1990-01       Impact factor: 4.180

2.  Spectrum of von Willebrand's Disease: a study of 100 cases. Italian Working Group.

Authors: 
Journal:  Br J Haematol       Date:  1977-01       Impact factor: 6.998

3.  Genetics of classic von Willebrand's disease. I. Phenotypic variation within families.

Authors:  C H Miller; J B Graham; L R Goldin; R C Elston
Journal:  Blood       Date:  1979-07       Impact factor: 22.113

4.  Intranasal and intravenous administration of desmopressin: effect on F VIII/vWF, pharmacokinetics and reproducibility.

Authors:  S Lethagen; A S Harris; E Sjörin; I M Nilsson
Journal:  Thromb Haemost       Date:  1987-12-18       Impact factor: 5.249

5.  DDAVP shortens the prolonged bleeding times of patients with severe von Willebrand disease treated with cryoprecipitate. Evidence for a mechanism of action independent of released von Willebrand factor.

Authors:  M Cattaneo; M Moia; P Delle Valle; P Castellana; P M Mannucci
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

Review 6.  von Willebrand disease: recent advances in pathophysiology and treatment.

Authors:  M D Phillips; A Santhouse
Journal:  Am J Med Sci       Date:  1998-08       Impact factor: 2.378

Review 7.  Diagnosis and management of von Willebrand's syndrome.

Authors:  M E Rick
Journal:  Med Clin North Am       Date:  1994-05       Impact factor: 5.456

8.  The effect of ABO blood group on the diagnosis of von Willebrand disease.

Authors:  J C Gill; J Endres-Brooks; P J Bauer; W J Marks; R R Montgomery
Journal:  Blood       Date:  1987-06       Impact factor: 22.113

9.  Epidemiological investigation of the prevalence of von Willebrand's disease.

Authors:  F Rodeghiero; G Castaman; E Dini
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

10.  Identification of a candidate missense mutation in a family with von Willebrand disease type IIC.

Authors:  R Schneppenheim; K B Thomas; S Krey; U Budde; U Jessat; A H Sutor; B Zieger
Journal:  Hum Genet       Date:  1995-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.